Pulmonary Arterial HypertensionNCT00621075
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
An observational study of Pulmonary Arterial Hypertension, run by Northwell Health at 1 site in United States.
Trial summary
The goal of our study is to correlate data from non-invasive tests such as perfusion lung scans with hemodynamic measurements from right heart catherizations. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Pulmonary Arterial Hypertension
- What is being tested?
- Pulmonary Arterial Hypertension - Lung Perfusion Scans
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2007to Feb 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Pulmonary Arterial Hypertension
Who may be able to join
- Pulmonary Arterial Hypertension
Who cannot join
- Non-Pulmonary Arterial Hypertension
Trial locations and contacts
1 site in 1 country.
United States1 site
North Shore-Lij Health System
New Hyde Park, New York, 11040
About this study
Official title: Correlation of Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
The goal of our study is to correlate data from non-invasive tests such as perfusion lung scans with hemodynamic measurements from right heart catherizations.
Read the detailed description
Data collected from PAH patients who have had non-invasive Ventilation/Perfusion testing, Echocardiography, Chest CT Scan, Pulmonary Function Testing and the correlation of those results to the hemodynamic parameters Right Heart Catherization results and the various biomarkers.
- Conditions
- Pulmonary Arterial Hypertension
- Being tested
- Pulmonary Arterial Hypertension - Lung Perfusion Scans
- Keywords
- PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs
- Medical subject headings
- Pulmonary Arterial Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pulmonary Arterial Hypertension - Lung Perfusion ScansOther
Also called Pulmonary Arterial Hypertension
Correlation of data from non-invasive tests such as lung perfusion scans with hemodynamic measurements
| Study group | Role | What they receive |
|---|---|---|
| 1 | Pulmonary Arterial Hypertension Receives: Other: Pulmonary Arterial Hypertension - Lung Perfusion Scans |
What is being measured
The primary outcome is the main question the study is designed to answer.
The correlation of patients' hemodynamic parameters with their perfusion index/pulmonary index as measured by ventilation perfusion scans in patients diagnosed with Pulmonary Hypertension.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Feb 2008 (estimated)
- Study startApr 2007
- Primary completionFeb 2008
- Study completionFeb 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulmonary Arterial HypertensionStudies of the same condition, open and under way.
- More trials run by Northwell HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Northwell Health
- Sponsor type
- University, hospital or other
- Investigators
- ARUNABH TALWAR, MD, Principal investigator, Northwell Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00621075
- Sponsor's protocol ID
- 07.014
- Other IDs
- NORTH SHORE IRB
- Status last verified
- Mar 2010
- First submitted
- 17 Jan 2008
- Last updated
- 9 Mar 2010
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Correlation of Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
- ClinicalTrials.gov ID
- NCT00621075
- Acronym / sponsor ID
- 07.014
- Conditions
- Pulmonary Arterial Hypertension
- Keywords
- PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Northwell HealthUniversity, hospital or other
- Study start
- Apr 2007
- Primary completion
- Feb 2008 (actual)
- Study completion
- Feb 2008 (actual)
- First posted
- 22 Feb 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of our study is to correlate data from non-invasive tests such as perfusion lung scans with hemodynamic measurements from right heart catherizations.
Detailed description
Data collected from PAH patients who have had non-invasive Ventilation/Perfusion testing, Echocardiography, Chest CT Scan, Pulmonary Function Testing and the correlation of those results to the hemodynamic parameters Right Heart Catherization results and the various biomarkers.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 | – | Other: Pulmonary Arterial Hypertension - Lung Perfusion ScansPulmonary Arterial Hypertension |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Pulmonary Arterial Hypertension
Key inclusion criteria (1 listed)
- Pulmonary Arterial Hypertension
Key exclusion criteria (1 listed)
- Non-Pulmonary Arterial Hypertension
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pulmonary Arterial Hypertension - Lung Perfusion ScansAlso: Pulmonary Arterial HypertensionCorrelation of data from non-invasive tests such as lung perfusion scans with hemodynamic measurements | Other | 1 |
Primary outcome
The correlation of patients' hemodynamic parameters with their perfusion index/pulmonary index as measured by ventilation perfusion scans in patients diagnosed with Pulmonary Hypertension.
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2010.
Related trials for Pulmonary Arterial Hypertension
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Not yet recruitingPhase 2
Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Active, not recruitingPhase 1
A Pilot Study of Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in Pulmonary Arterial Hypertension (GUT RESTORE-PAH)
Pulmonary Arterial Hypertension
RecruitingObservational study
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Pulmonary Disease, Pulmonary Hypertension
Active, not recruitingPhase 1
Study of Intravenous ZMA001 in Healthy Subjects
Pulmonary Arterial Hypertension PAH
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
ARUNABH TALWAR, MD principal investigator
Northwell Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pulmonary Arterial Hypertension, run by Northwell Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Mar 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The correlation of patients' hemodynamic parameters with their perfusion index/pulmonary index as measured by ventilation perfusion scans in patients diagnosed with Pulmonary Hypertension. (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2010.